Patients with DMG with FOXR2 overexpression were younger at diagnosis (6.0 vs 9.1 years, P = 0.007), but rates of metastatic disease at diagnosis, gender, and extent of resection were similar. The gene discussed is FOXR2; the disease is metastatic neoplasm.